Summary:
Craniofrontonasal syndrome (CFNS) is a rare X-linked disorder that shows greater severity in females and is largely attributed to mutations in EFNB1. A 7-year-old boy presented with hypertelorism, broad nasal root, midfacial hypoplasia, mandibular prognathia, ptosis, and scaphocephaly was clinically diagnosed with CFNS. Three-dimensional computed tomographic scans confirmed the isolated sagittal synostosis. His mother also showed clinical features of CFNS, but less severe. Genetic tests uncovered a novel C to T mutation at nucleotide 466 (c.466C>T) in exon 1 of EFNB1 for both. To the best of our knowledge, this is the only reported incident of CFNS in a male child exhibiting isolated sagittal synostosis.
Craniofrontonasal syndrome (CFNS) is a rare X-linked syndrome commonly associated with mutations in EFNB1.1–3 It is characterized by a more severe phenotype in heterozygous females,4 which typically display dysmorphic features including bicoronal synostosis, hypertelorism, broad nasal root with bifid tip, brachycephaly, frontal bossing, corpus callosum agenesis, and thick wiry hair with orbital asymmetry and strabismus.5 The extracranial features include multiple skeletal malformations, such as sloping shoulders, dysplastic clavicles, thoracic skeleton asymmetry, and unilateral breast hypoplasia, in addition to longitudinally grooved fingernails, mild cutaneous syndactyly, and umbilical or diaphragmatic hernia. Sagittal synostosis has been reported in one female with CFNS, where the sagittal synostosis was accompanied by bicoronal synostosis.6 Hemizygous males usually manifest hypertelorism, cleft lip, and/or cleft palate.7 However, unilateral or bilateral coronal craniosynostosis among 8 male children with CFNS have been reported.8–12 Herein, we report a 7-year-old boy diagnosed with a novel CFNS phenotype, chiefly isolated sagittal synostosis, arising from a previously unreported EFNB1 mutation.
CLINICAL REPORT
A 7-year-old boy with sagittal synostosis was referred for ophthalmic evaluation to rule out raised intracranial pressure. His family history was unremarkable. However, on examination, his mother was noted to have hypertelorism and a broad nasal tip along with a medical history of an umbilical hernia and widely spaced incisors. The patient’s initial symptoms included frequent headaches, history of obstructive sleep apnea, and abnormal head shape. Examination confirmed scaphocephaly, microcephaly, midfacial hypoplasia, mandibular prognathia, ptosis with upslanting palpebral fissures, large ears (>97th percentile), broad nasal root and bridge with an inner canthal distance of 3.7 cm (>97th percentile), and interpupillary distance of 6.9 cm (>97th percentile) suggestive of hypertelorism (Fig. 1). His intraoral examination revealed an intact palate with class III malocclusion and widely spaced incisors. A three-dimensional computed tomographic scan of the head (Fig. 2) revealed fusion of the sagittal suture only and mandibular prognathia with crowding of the teeth. Fundus examination was negative for papilledema, but revealed bilateral mild exocyclotorsion of the fundi. The patient also exhibited hyperopia with astigmatism in both eyes. The facial appearance together with the eye findings pointed to a diagnosis of CFNS.
Fig. 1.

Seven-year-old boy with CFNS. A, Frontal view of the 7-year-old boy displaying microcephaly, hypertelorism, broad nasal root, ptosis, mandibular prognathia, and midface hypoplasia. B, Side profile of the boy showing large ears, mandibular prognathia, midface hypoplasia, and, together with the left-hand panel, scaphocephaly.
Fig. 2.

Computed tomography scans demonstrating sagittal synostosis, mandibular prognathia, and dental crowding in the lower mandible. A, Front view. B, Right-side profile.
GENETIC TESTING
All genetic testing were conducted in laboratories certified under the Clinical Laboratory Improvement Amendments of 1988. Previous genetic testing of the patient included a karyotype at a 600 G-band level of resolution and an oligoarray, both of which demonstrated a normal chromosomal complement. After the ophthalmic examination, venous blood was drawn and genomic DNA extracted. Sequencing of exons 1 through 5 of EFNB1 revealed a novel C to T mutation at nucleotide 466 in exon 1 (c.466C>T) (Fig. 3A), which changes a codon for the nonpolar arginine to the polar cysteine at amino acid 156 (p.Arg156Cys) (Fig. 3B). This arginine is highly conserved from mammals, chicken, frogs, and zebrafish in addition to being conserved in EFNB2 and EFNB3. The amino acid change is at the terminus end of the EFNB1 ephrin receptor-binding domain, the main functional domain. The mother was found to have the same mutation with a less severe phenotype, whereas the younger brother was negative for site-specific mutation analysis and had no signs of CFNS. Written informed consent was obtained from the mother of the child for being included in the study.
Fig. 3.

A, Chromatogram showing the C to T missense mutation at nucleotide 466 (c.466C>T) in EFNB1. The top portion is the reference genome and the bottom portion is the patient sample showing the missense mutation at position 466 (denoted by ^). B, Missense mutation, p.Arg156Cys (denoted by ^), in the RBD of EFNB1. The protein structure of human EFNB1 is shown at the top. Amino acid sequence alignments from several vertebrate species in the region of the missense mutation are at the bottom, together with the human sequence alignments for human EFNB1, 2, and 3 in the same region. The numbers refer to amino acid positions for the human EFNB1 protein. Chk indicates chicken; Gor, gorilla; Hu, human; M, mouse; RBD, receptor-binding domain; TM, transmembrane; XL, Xenopus laevis (frog); Zf, zebrafish.
DISCUSSION
Although sagittal synostosis has been previously reported in a girl with CFNS, the synostosis was multisutural and included bilateral coronal synostosis.6 CFNS is associated with mutations in 1 of 5 exons in EFNB1 at chromosome Xq13.1, 42% of which are missense changes in exons 2 or 3 that encode the extracellular domain. Mutations in the cytoplasmic domain encoded by exons 4 and 5 (Fig. 3B) have also resulted in CFNS.7,13 Previously described mutations in the gene have accounted for coronal craniosynostosis,2,13,14 and a review of the literature failed to reveal any individual (male or female) affected by isolated sagittal synostosis.
Genetic testing revealed a missense mutation at position 466 of EFNB1 from a C to a T in exon 1, leading to an amino acid substitution of an arginine to a cysteine at amino acid 156 (p.Arg156Cys). This arginine is highly conserved not only among several vertebrate species, ranging from fish to primates, but also among human EFNB members 1–3.
EFNB1 has several basic functions in cell adhesion, migration, and patterning15–18 to regulate many developmental roles, including bone formation,19,20 skeletogenesis,21 neuronal wiring,22,23 angiogenesis,24 and retinocollicular mapping,25 in addition to disease monitoring such as inflammation26 and blood pressure monitoring.27 Previous characterization of the EFNB1 protein structure28 enabled the location of the highly conserved arginine to be determined within the essential receptor-binding domain in the extracellular region. This domain binds to the Eph receptor, and loss of binding to the receptor leads to craniofacial defects such as CFNS.2 The mechanism explaining the more severe phenotype in affected heterozygote females compared with homozygous males is unclear, but the random X-inactivation in heterozygote females leading to the mosaic state is the most likely explanation. This is because with transmembrane proteins, such as EFNB1, cellular interference between normal and mutant EFNB1-expressing cell populations leads to the diseased condition.9
CONCLUSIONS
We present a case of isolated sagittal synostosis in a male child with a novel mutation in the EFNB1. This case is significant when providing genetic diagnosis and counseling in families suspected of CFNS or in females with known EFNB1 mutations. Also unusually, the child is more severely affected when compared with his mother who shares the same mutation. We propose the differential diagnosis of CFNS be expanded to include isolated sagittal synostosis in the presence of other suggestive facial dysmorphology, such as hypertelorism, broad nasal tip, or widely spaced incisors, and that this diagnosis be considered in both males and females with suggestive symptoms.
PATIENT CONSENT
Parents or guardians provided written consent for the use of the patient's image.
Footnotes
Presented at the 9th U.K. Eye Genetics Group Meeting, 2013, UCL Institute of Child Health, London, United Kingdom, January 18th, 2013.
Disclosure: The authors have no financial interest to declare in relation to the content of this article. This study was funded by an unrestricted grant from Research to Prevent Blindness (RPB), New York, N.Y., and the National Institutes of Health CORE Grant P30 EY008098 to the Eye and Ear Foundation of Pittsburgh, Pa. The Article Processing Charge was paid for by the authors.
REFERENCES
- 1.Wieland I, Jakubiczka S, Muschke P, et al. Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome. Am J Hum Genet. 2004;74:1209–1215. doi: 10.1086/421532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Twigg SR, Kan R, Babbs C, et al. Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci U S A. 2004;101:8652–8657. doi: 10.1073/pnas.0402819101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Apostolopoulou D, Stratoudakis A, Hatzaki A, et al. A novel de novo mutation within EFNB1 gene in a young girl with craniofrontonasal syndrome. Cleft Palate Craniofac J. 2012;49:109–113. doi: 10.1597/10-247. [DOI] [PubMed] [Google Scholar]
- 4.Zafeiriou DI, Pavlidou EL, Vargìami E. Diverse clinical and genetic aspects of craniofrontonasal syndrome. Pediatr Neurol. 2011;44:83–87. doi: 10.1016/j.pediatrneurol.2010.10.012. [DOI] [PubMed] [Google Scholar]
- 5.Wieacker P, Wieland I. Clinical and genetic aspects of craniofrontonasal syndrome: towards resolving a genetic paradox. Mol Genet Metab. 2005;86:110–116. doi: 10.1016/j.ymgme.2005.07.017. [DOI] [PubMed] [Google Scholar]
- 6.van den Elzen ME, Twigg SR, Goos JA, et al. Phenotypes of craniofrontonasal syndrome in patients with a pathogenic mutation in EFNB1. Eur J Hum Genet. 2014;22:995–1001. doi: 10.1038/ejhg.2013.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wieland I, Reardon W, Jakubiczka S, et al. Twenty-six novel EFNB1 mutations in familial and sporadic craniofrontonasal syndrome (CFNS). Hum Mutat. 2005;26:113–118. doi: 10.1002/humu.20193. [DOI] [PubMed] [Google Scholar]
- 8.Kwee ML, Lindhout D. Frontonasal dysplasia, coronal craniosynostosis, pre- and postaxial polydactyly and split nails: a new autosomal dominant mutant with reduced penetrance and variable expression? Clin Genet. 1983;24:200–205. doi: 10.1111/j.1399-0004.1983.tb02240.x. [DOI] [PubMed] [Google Scholar]
- 9.Twigg SR, Babbs C, van den Elzen ME, et al. Cellular interference in craniofrontonasal syndrome: males mosaic for mutations in the X-linked EFNB1 gene are more severely affected than true hemizygotes. Hum Mol Genet. 2013;22:1654–1662. doi: 10.1093/hmg/ddt015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kapusta L, Brunner HG, Hamel BC. Craniofrontonasal dysplasia. Eur J Pediatr. 1992;151:837–841. doi: 10.1007/BF01957936. [DOI] [PubMed] [Google Scholar]
- 11.Evers C, Jungwirth MS, Morgenthaler J, et al. Craniofrontonasal syndrome in a male due to chromosomal mosaicism involving EFNB1: further insights into a genetic paradox. Clin Genet. 2014;85:347–353. doi: 10.1111/cge.12171. [DOI] [PubMed] [Google Scholar]
- 12.Natarajan U, Baraitser M, Nicolaides K, et al. Craniofrontonasal dysplasia in two male sibs. Clin Dysmorphol. 1993;2:360–364. [PubMed] [Google Scholar]
- 13.Shotelersuk V, Siriwan P, Ausavarat S. A novel mutation in EFNB1, probably with a dominant negative effect, underlying craniofrontonasal syndrome. Cleft Palate Craniofac J. 2006;43:152–154. doi: 10.1597/05-014.1. [DOI] [PubMed] [Google Scholar]
- 14.Wolfswinkel EM, Weathers WM, Correa B, et al. Craniofrontonasal dysplasia: variability of the frontonasal suture and implications for treatment. J Craniofac Surg. 2013;24:1303–1306. doi: 10.1097/SCS.0b013e3182942b5c. [DOI] [PubMed] [Google Scholar]
- 15.Rohani N, Canty L, Luu O, et al. EphrinB/EphB signaling controls embryonic germ layer separation by contact-induced cell detachment. PLoS Biol. 2011;9:e1000597. doi: 10.1371/journal.pbio.1000597. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Coulthard MG, Duffy S, Down M, et al. The role of the Eph-ephrin signalling system in the regulation of developmental patterning. Int J Dev Biol. 2002;46:375–384. [PubMed] [Google Scholar]
- 17.Lee HS, Daar IO. EphrinB reverse signaling in cell-cell adhesion: is it just par for the course? Cell Adh Migr. 2009;3:250–255. doi: 10.4161/cam.3.3.8211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Poliakov A, Cotrina M, Wilkinson DG. Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell. 2004;7:465–480. doi: 10.1016/j.devcel.2004.09.006. [DOI] [PubMed] [Google Scholar]
- 19.Cheng S, Kesavan C, Mohan S, et al. Transgenic overexpression of ephrin b1 in bone cells promotes bone formation and an anabolic response to mechanical loading in mice. PLoS One. 2013;8:e69051. doi: 10.1371/journal.pone.0069051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Xing W, Kim J, Wergedal J, et al. Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1. Mol Cell Biol. 2010;30:711–721. doi: 10.1128/MCB.00610-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Compagni A, Logan M, Klein R, et al. Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell. 2003;5:217–230. doi: 10.1016/s1534-5807(03)00198-9. [DOI] [PubMed] [Google Scholar]
- 22.Klein R, Kania A. Ephrin signalling in the developing nervous system. Curr Opin Neurobiol. 2014;27:16–24. doi: 10.1016/j.conb.2014.02.006. [DOI] [PubMed] [Google Scholar]
- 23.Sentürk A, Pfennig S, Weiss A, et al. Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration. Nature. 2011;472:356–360. doi: 10.1038/nature09874. [DOI] [PubMed] [Google Scholar]
- 24.Kuijper S, Turner CJ, Adams RH. Regulation of angiogenesis by Eph-ephrin interactions. Trends Cardiovasc Med. 2007;17:145–151. doi: 10.1016/j.tcm.2007.03.003. [DOI] [PubMed] [Google Scholar]
- 25.Thakar S, Chenaux G, Henkemeyer M. Critical roles for EphB and ephrin-B bidirectional signalling in retinocollicular mapping. Nat Commun. 2011;2:431. doi: 10.1038/ncomms1445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Mori T, Maeda N, Inoue K, et al. A novel role for adipose ephrin-B1 in inflammatory response. PLoS One. 2013;8:e76199. doi: 10.1371/journal.pone.0076199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wu Z, Luo H, Thorin E, et al. Possible role of Efnb1 protein, a ligand of Eph receptor tyrosine kinases, in modulating blood pressure. J Biol Chem. 2012;287:15557–15569. doi: 10.1074/jbc.M112.340869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Fletcher FA, Huebner K, Shaffer LG, et al. Assignment of the gene (EPLG2) encoding a high-affinity binding protein for the receptor tyrosine kinase elk to a 200-kilobasepair region in human chromosome Xq12. Genomics. 1995;25:334–335. doi: 10.1016/0888-7543(95)80156-g. [DOI] [PubMed] [Google Scholar]
